Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference53 articles.
1. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
2. Cantlay A, Glyn T, Barton N. Polypharmacy in the elderly. InnovAiT. 2016;9(2):69–77.
3. Canadian Institute for Health Information. Seniors and the health care system: what is the impact of multiple chronic conditions? (2011). Available: https://secure.cihi.ca/free_products/air-chronic_disease_aib_en.pdf. Accessed 27 Jan 2021.
4. Reason B, Terner M, Moses McKeag A, Tipper B, Webster G. The impact of polypharmacy on the health of Canadian seniors. Fam Pract. 2012;29(4):427–32.
5. Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.